Document is current

Article History

Received: 24 December 2024

Accepted: 28 March 2025

First Online: 21 April 2025

Declarations

:

: MD: has received consulting fees and honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Amgen, Astra Zeneca, BeiGene, Bristol-Myers Squibb, GlaxoSmithKline K.K., Janssen Pharmaceuticals, Menarini Group, Regeneron Pharmaceuticals, Sanofi, Swixx Biopharma and Takeda. KS: has received honoraria from Bristol-Myers Squibb, Janssen Pharmaceuticals, Ono Pharmaceutical and Sanofi, and research funding from AbbVie GK, Bristol-Myers Squibb, Celgene Corporation, Chugai Pharmaceutical Co. Ltd., GlaxoSmithKline K.K., Janssen Pharmaceuticals, Kyowa Kirin, MSD, Novartis, Ono Pharmaceutical, Otsuka Pharmaceutical, Pfizer Japan Inc., Sanofi and Takeda. XL: has for received consulting fees, support for attending meetings and/or travel, honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events, and has participated on a data safety monitoring board or advisory board of Sanofi. RV: has received honoraria from Bristol-Myers Squibb, Janssen Pharmaceuticals, Karyopharm, Pfizer, Regeneron Pharmaceuticals and Sanofi, and grant support from Bristol-Myers Squibb, Sanofi and Takeda. CG: has received clinical trial/contracts with Bristol-Myers Squibb, Karyopharm, AbbVie, Caribou and K36 Therapeutics; honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Bristol-Myers Squibb, Karyopharm and Sanofi; support for attending meetings and/or travel from Sanofi; participated on a data safety monitoring board or advisory board for Bristol-Myers Squibb, GlaxoSmithKline K.K., Pfizer and Janssen Pharmaceuticals; and has a leadership or fiduciary role in Bristol-Myers Squibb. KS: has received lecture fees from Bristol-Myers Squibb Takeda, Ono Pharmaceutical, Novartis, Sanofi, AbbVie and Janssen. SM and KT are employees of Sanofi. MH is employee and has stock of Sanofi. SI: has received honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Astra Zeneca, Bristol-Myers Squibb, Janssen, Ono, Pfizer, Sanofi and Takeda; consulting fees from AbbVie GK, Bristol-Myers Squibb, GlaxoSmithKline K.K., Janssen Pharmaceuticals K.K., Novartis, Pfizer, Sanofi KK and Takeda Pharmaceutical Co., Ltd.; research grants from AbbVie GK, Amgen K.K., Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Limited, GlaxoSmithKline K.K., Janssen Pharmaceutical K.K., Novartis, Ono Pharmaceutical Co., Ltd., Pfizer Japan Inc., Sanofi K.K., Shionogi & Co., Ltd. and Takeda Pharmaceutical Co., Ltd.